Multielectrode catheter-based pulsed electric field vs. cryoballoon for atrial fibrillation ablation: a systematic review and meta-analysis

EP Europace Journal

23 November 2024
Organised by: Logo
ESC Journals ARRHYTHMIAS AND DEVICE THERAPY Atrial Fibrillation (AF)

Abstract

AbstractAims

Pulsed field ablation (PFA) is an innovative technology recently adopted for the treatment of atrial fibrillation (AF). Preclinical and clinical studies have reported a remarkable safety profile, as a result of its tissue-specific effect targeting cardiomyocytes and sparing adjacent tissues. Single-shot pentaspline system was the first PFA device to receive regulatory approval. We performed a meta-analysis to compare the efficacy and safety of PFA with the single-shot pentaspline system vs. currently available second-/third-/fourth-generation cryoballoon ablation (CRYO) technologies.

Methods and results

We systematically searched electronic databases for studies focusing on AF ablation employing the PFA single-shot pentaspline system or second-/third-/fourth-generation CRYO technologies. The primary endpoints were acute procedural success assessed on a vein and patient basis. Safety endpoints included overall periprocedural complications and major periprocedural complications. We also compared procedural, fluoroscopy times, and freedom from atrial tachyarrhythmias (ATs) at follow-up (secondary endpoints). Twenty and 70 studies were included for PFA and CRYO, respectively. Pulsed field ablation demonstrated greater acute procedural success on a vein basis (99.9% vs. 99.1%; P < 0.001), as well as per patient (99.5% vs. 98.4%; P < 0.001). Pulsed field ablation yielded lower overall periprocedural complications (3.1% vs. 5.6%; P < 0.001), shorter procedural time (75.9 min vs. 105.6 min; P < 0.001), and fluoroscopy time (14.2 min vs. 18.9 min; P < 0.001) compared with CRYO. No differences were found for major periprocedural complications (1.2% vs. 1.0%; P = 0.46) and freedom from ATs at 1 year (82.3% vs. 80.3%; log-rank P = 0.61).

Conclusion

Pulsed field ablation contributed to higher acute procedural success and safety compared with CRYO. No statistically significant differences in AT recurrence at 1-year follow-up were observed.

Contributors

Alvise Del Monte
Alvise Del Monte

Author

University Hospital (UZ) Brussels Brussels , Belgium

Alexandre Almorad
Alexandre Almorad

Author

University Hospital (UZ) Brussels Brussels , Belgium

Lorenzo Marcon
Lorenzo Marcon

Author

University Hospital (UZ) Brussels Brussels , Belgium

Ioannis Doundoulakis
Ioannis Doundoulakis

Author

Vrije University Brussels Brussels , Belgium

Giampaolo Vetta
Giampaolo Vetta

Author

University Hospital (UZ) Brussels Brussels , Belgium

Charles Audiat
Charles Audiat

Author

CHU Saint Pierre Brussels , Belgium

Domenico Giovanni Della Rocca
Domenico Giovanni Della Rocca

Author

University Hospital (UZ) Brussels Brussels , Belgium

Ingrid Overeinder
Ingrid Overeinder

Author

University Hospital (UZ) Brussels Brussels , Belgium

Luigi Pannone
Luigi Pannone

Author

University Hospital (UZ) Brussels Brussels , Belgium

Andrea Natale
Andrea Natale

Author

St. David's Medical Center Austin , United States of America